CompoAtlas

Bio Green Heron QF Granule

Bio Green Heron QF Granule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Gypsum fibrosumGypsum fibrosum[706 mg,6 gm]Not identified
Poria cocosPoria cocos[589 mg,6 gm]Not identified
Bupleurum chinenseBupleurum chinense[589 mg,6 gm]Not identified
Dioscorea oppositaDioscorea opposita[505 mg,6 gm]Not identified
Lonicera japonicaLonicera japonica[364 mg,6 gm]Not identified
Mosla chinensisMosla chinensis[336 mg,6 gm]Not identified
Prunus armeniacaPrunus armeniaca[336 mg,6 gm]Not identified
Cinnamomum cassiaCinnamomum cassia[336 mg,6 gm]Not identified
Alisma orientaleAlisma orientale[336 mg,6 gm]Not identified
Polyporus umbellatusPolyporus umbellatus[336 mg,6 gm]Not identified
Atractylodes macrocephalaAtractylodes macrocephala[336 mg,6 gm]Not identified
Pinellia ternataPinellia ternata[336 mg,6 gm]Not identified
Zingiber officinaleZingiber officinale[336 mg,6 gm]Not identified
Aster tataricusAster tataricus[336 mg,6 gm]Not identified
Tussilago farfaraTussilago farfara[336 mg,6 gm]Not identified
Belamcanda chinensisBelamcanda chinensis[336 mg,6 gm]Not identified
Pogostemon cablinPogostemon cablin[336 mg,6 gm]Not identified
Scutellaria baicalensisScutellaria baicalensis[252 mg,6 gm]Not identified
Citrus reticulataCitrus reticulata[252 mg,6 gm]Not identified
Glycyrrhiza uralensisGlycyrrhiza uralensis[235 mg,6 gm]Not identified
Saposhnikovia divaricataSaposhnikovia divaricata[235 mg,6 gm]Not identified
Citrus aurantiumCitrus aurantium[235 mg,6 gm]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL20116046T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
WHITE HERON PHARMACEUTICAL SDN. BHD.
Manufacturer
WHITE HERON PHARMACEUTICAL SDN. BHD.
Registration period starting
2025-11-19
Published validity end
2030-11-19

Original register data

View published fields and their variants
Active ingredients
Gypsum fibrosum[706 mg,6 gm],Poria cocos[589 mg,6 gm],Bupleurum chinense[589 mg,6 gm],Dioscorea opposita[505 mg,6 gm],Lonicera japonica[364 mg,6 gm],Mosla chinensis[336 mg,6 gm],Prunus armeniaca[336 mg,6 gm],Cinnamomum cassia[336 mg,6 gm],Alisma orientale[336 mg,6 gm],Polyporus umbellatus[336 mg,6 gm],Atractylodes macrocephala[336 mg,6 gm],Pinellia ternata[336 mg,6 gm],Zingiber officinale[336 mg,6 gm],Aster tataricus[336 mg,6 gm],Tussilago farfara[336 mg,6 gm],Belamcanda chinensis[336 mg,6 gm],Pogostemon cablin[336 mg,6 gm],Scutellaria baicalensis[252 mg,6 gm],Citrus reticulata[252 mg,6 gm],Glycyrrhiza uralensis[235 mg,6 gm],Saposhnikovia divaricata[235 mg,6 gm],Citrus aurantium[235 mg,6 gm]
Valid until
2030-11-19
Registration date
2025-11-19
Published description
NATURAL PRODUCT
Licence holder
WHITE HERON PHARMACEUTICAL SDN. BHD.
Producer
WHITE HERON PHARMACEUTICAL SDN. BHD.
Published name
Bio Green Heron QF Granule
Published reference
202005203748T
Registration number
MAL20116046T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL20116046T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Cinnamomum cassia
    Read the warning, when it applies and the studies cited

    CASSIA - CINNAMOMUM AROMATICUM

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Appetite loss; Digestive disturbances/Indigestion; Traditional Chinese Medicine claims.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (2)
    • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council; 2000.
    • WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Gardner and McGuffin 2013; Brinker 2010).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Contraindications

    Applies to products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day.

    Do not use if you are pregnant (PPRC 2020; Brinker 2010; BHC 2006; Chen and Chen 2004; Blumenthal 2000, 1998).

    Sources cited by Health Canada (6)
    • BHC 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drugs - Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council; 2000.
    • Blumenthal M, editor. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council in cooperation with Integrative Medicine Communications; 1998.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
    • PPRC 2020: Pharmacopoeia of the People's Republic of China. Volume 1, English edition. Beijing (CN): The State Pharmacopoeia Commission of the People's Republic of China; 2020.

    Condition of application: Traditional Chinese Medicine claims.

    Do not use if you have excess heat, blood heat or deficiency, or yin-deficient fire (PPRC 2020; Bensky et al. 2004; Chen and Chen 2004).

    Sources cited by Health Canada (3)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
    • PPRC 2020: Pharmacopoeia of the People's Republic of China. Volume 1, English edition. Beijing (CN): The State Pharmacopoeia Commission of the People's Republic of China; 2020.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Gardner and McGuffin 2013; Blumenthal 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council; 2000.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
    • WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.

    Health Canada monograph dated 30 May 2025

  • Zingiber officinale
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    Sources cited by Health Canada (1)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    Sources cited by Health Canada (2)
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    Sources cited by Health Canada (4)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Bio Green Heron QF Granule”, https://compoatlas.com/en/supplements/malaysia/MAL20116046T-bio-green-heron-qf-granule, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line